Sirona Biochem Corp. (CVE:SBM – Get Free Report)’s stock price fell 16.7% on Tuesday . The stock traded as low as C$0.05 and last traded at C$0.05. 113,000 shares were traded during mid-day trading, an increase of 91% from the average session volume of 59,069 shares. The stock had previously closed at C$0.06.
Sirona Biochem Stock Performance
The firm has a market capitalization of C$12.84 million, a price-to-earnings ratio of -5.00 and a beta of -0.03. The company has a quick ratio of 2.41, a current ratio of 0.34 and a debt-to-equity ratio of 219.21. The stock’s fifty day moving average is C$0.06 and its two-hundred day moving average is C$0.06.
Sirona Biochem Company Profile
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program.
Read More
- Five stocks we like better than Sirona Biochem
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- Basic Materials Stocks Investing
- What Does the Future Hold for Eli Lilly?
- How to Use Stock Screeners to Find Stocks
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Sirona Biochem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sirona Biochem and related companies with MarketBeat.com's FREE daily email newsletter.
